OceanaGold says share price surge may reflect rising gold price

OceanaGold,  the Melbourne-based gold miner, said it isn't aware of any material information requiring disclosure which would account for its share price rise.

The company's shares surged 9.3 percent to $3.41, their highest since March 2013. The stock is the best performer on the NZX 50 benchmark index today, one of only five stocks to gain with the broader index down 0.5 percent. Its shares are also listed in Australia and Toronto.

"Changes in the company's share price this morning on the NZX is likely due to an increase in gold prices overnight, as well as a corresponding increase in the share value of the company and its peer group over the same period on the TSX and ASX," OceanaGold said in a statement.

Gold prices touched a three-week high yesterday, buoyed by safe-haven demand prompted by unrest in Iraq.

OceanaGold's shares resumed trading at 1:03pm, having been halted at 12:14pm pending the company's statement.

BusinessDesk.co.nz

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

NZ dollar eases on technical factors, buoyed by higher dairy prices
RBNZ eyes Westpac Australia money laundering failures
Heritage buys Golden Healthcare; not mystery Metlife suitor
Alliance margins improve as swine fever boosts global meat prices
RBNZ eyes Westpac Australia money laundering failures
Precinct eyes new developments as Commercial Bay keeps to revised schedule
End to Tower's three year dividend drought in sight
Vital Healthcare's manager appoints new independent director
Argosy lifts first-half profit 15.2% on valuation gains
Metlifecare attracts 'credible' bidder after biggest trading day in 2 1/2 years